Gyroscope Therapeutics Limited acquired Orbit Biomedical Limited from Syncona Portfolio Ltd and other shareholders on April 11, 2019. Khurem Farooq will join as the new Chief Executive Officer of Gyroscope Therapeutics Limited. Soraya Bekkali will continue to lead Gyroscope as the President and Head of Research and Development. Susan Hill will be join as the Chief Business Officer of Gyroscope. Mike Keane, the founder of Orbit Biomedical will act as the Chief Technology Officer of Gyroscope and will continue to oversee the Orbit platform and its application to internal programs and external partnerships. Ashwin Datt will join as the Chief People Officer of Gyroscope. Ian Clark has been appointed as the Non-Executive Director of Gyroscope. Gyroscope Therapeutics Limited completed the acquisition of Orbit Biomedical Limited from Syncona Portfolio Ltd and other shareholders on April 11, 2019.